Advertisement
Advertisement
CVKD
Cadrenal Therapeutics, Inc. Common Stock
19.23
USD+0.47
+2.47%
Feb 21, 15:42 UTC -5
Closed
Pre-Market
19.726
-0.16
-0.82%
Cadrenal Therapeutics, Inc. Common Stock Profile
About
Info & Links
CEO
Quang Pham
Headquarters
Ponte Vedra, FL 32082, UNITED STATES
Industry
Sector
Website
Auditor
WithumSmith+Brown, PC
Share holders
28
Employees
4
Cadrenal Therapeutics, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
32.72M
Enterprise Value
28.36M
Enterprise Value/EBITDA(ttm)
-3.57
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
6.96
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
0.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
0.00%
Return on Equity(ttm)
-142.95%
Return on Invested Capital(ttm)
-172.24%
Return on Assets(ttm)
-118.40%
Income Statement
Revenue(ttm)
0.00
Revenue Per Share(ttm)
0.00
Gross Profit(ttm)
0.00
EBITDA(ttm)3
-7.94M
Net Income Available to Common(ttm)
-7.61M
Diluted EPS(ttm)
-6.68
Share Statistics
Beta (5Y Monthly)
1.37
52-Week Change
103.44%
S&P 500 52-Week Change
18.61%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
1.66M
Dividend Yield
0.00%
Float4
916.00K
% Held by Insiders
48.62%
% Held by Institutions
7.92%
Balance Sheet
Total Cash(mrq)
4.36M
Total Cash Per Share(mrq)
2.63
Total Debt(mrq)
0.00
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
3.69%
Quick Ratio(mrq)
3.69%
Book Value Per Share(mrq)
2.76
Cash Flow
Operating Cash Flow Per Share(ytd)
-5.04
Free Cash Flow(ytd)
-5.57M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement